Neuraxis Inc (NRXS)

AMEX

$7.01

NeurAxis, Inc. is a neuromodulation therapy device company in the United States. The company is headquartered in Versailles, Indiana.

Sector:

Industry:

68 analysts

Buy

Target: $11 (+56.92%)

Market Cap

$80M

Free Cash Flow Yield

-7.60%

Beta (5Y)

1.00

Adjust inflation

Log

Valuation

Market Cap$80M

P/S20.19

P/B15.42

Profitability

Total Revenue (TTM)$4.28M

Gross Profit (TTM)$3.64M

EBITDA-$7.21M

Profit Margin-170.1%

Operating Margin-108.3%

EPS-$0.70

Financial Health

Debt-to-Equity1.8%

Free Cash Flow Yield-7.60%

Growth & Risk

Beta (5Y)1.00

Sharpe Ratio1.66